Submitted:
25 October 2023
Posted:
26 October 2023
You are already at the latest version
Abstract
Keywords:
“Mother Nature is a self-taught engineer.”― Stewart Stafford, Actor, Hollywood
“Covid has magnified every existing inequality”― Melinda Gates, American Philanthropist
“We long to return to normal, but normal led to this. To avert the future pandemics we know are coming, we MUST grapple with all the ways normal failed us. We have to build something better. I hope this piece, in showing what went wrong, helps.”― Ed Yong, Science Journalist, The Atlantic
Origin of SARS-CoV-2 – arguments in favor of the Natural evolution theory
Not the early source but still worth to be mentioned – the Lab-leak hypothesis
Paired comparison analysis: Reasons behind the emergence of SARS-CoV-2
Current therapeutic measures and future directions
References
- Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., and Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine 26, 450–452. [CrossRef]
- Antonio, A. da S., Wiedemann, L. S. M., and Veiga-Junior, V. F. (2020). Natural products’ role against COVID-19. RSC Adv. 10, 23379–23393. [CrossRef]
- Balaram, P. (2021). The murky origins of the Coronavirus SARS-CoV-2, the causative agent of the COVID-19 pandemic. Current Science, 1663–1666.
- Basu, S. (2021). Special Issue on ‘Coronavirus: Vaccines and Other Therapeutics’ (2020–2021). Vaccines 9, 1083. [CrossRef]
- Basu, S., Chakravarty, D., Bhattacharyya, D., Saha, P., and Patra, H. K. (2021). Plausible blockers of Spike RBD in SARS-CoV2—molecular design and underlying interaction dynamics from high-level structural descriptors. J Mol Model 27, 191. [CrossRef]
- Bertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirss, K., Nehlmeier, I., et al. (2011). Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 85, 13363–13372. [CrossRef]
- Cacciapaglia, G., Cot, C., and Sannino, F. (2021). Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases. Sci Rep 11, 6638. [CrossRef]
- Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S. M., Walsh, R. M., et al. (2020). Distinct conformational states of SARS-CoV-2 spike protein. Science. [CrossRef]
- Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., et al. (2020). De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science 370, 426–431. [CrossRef]
- Chan, Y. A., and Zhan, S. H. (2021). The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2. Molecular Biology and Evolution, msab327. [CrossRef]
- Chu, K.-B., Kang, H.-J., Yoon, K.-W., Lee, H.-A., Moon, E.-K., Han, B.-K., et al. (2021). Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines 9, 920. [CrossRef]
- Dance, A. (2021). The shifting sands of ‘gain-of-function’ research. Nature 598, 554–557. [CrossRef]
- Dudas, G., Carvalho, L. M., Rambaut, A., and Bedford, T. (2018). MERS-CoV spillover at the camel-human interface. eLife 7. [CrossRef]
- Enuh, H. A., Ezedunukwe, I. R., and Oragwu, C. I. (2018). Influenza vaccine for people with HIV/AIDS. Cochrane Database Syst Rev 2018, CD003509. [CrossRef]
- Fact Sheet: Activity at the Wuhan Institute of Virology United States Department of State. Available at: https://2017-2021.state.gov/fact-sheet-activity-at-the-wuhan-institute-of-virology/ [Accessed May 28, 2022].
- Frutos, R., Gavotte, L., and Devaux, C. A. (2021). Understanding the origin of COVID-19 requires to change the paradigm on zoonotic emergence from the spillover to the circulation model. Infection, Genetics and Evolution 95, 104812. [CrossRef]
- Fujiwara, S. (2018). Humanized mice: A brief overview on their diverse applications in biomedical research. J Cell Physiol 233, 2889–2901. [CrossRef]
- Gong, P. (2021). “Chapter Eight - Structural basis of viral RNA-dependent RNA polymerase nucleotide addition cycle in picornaviruses,” in The Enzymes Viral Replication Enzymes and their Inhibitors Part A., eds. C. E. Cameron, J. J. Arnold, and L. S. Kaguni (Academic Press), 215–233. [CrossRef]
- Huang, J., Tao, G., Liu, J., Cai, J., Huang, Z., and Chen, J. (2020). Current Prevention of COVID-19: Natural Products and Herbal Medicine. Frontiers in Pharmacology 11, 1635. [CrossRef]
- Huo, J., Le Bas, A., Ruza, R. R., Duyvesteyn, H. M. E., Mikolajek, H., Malinauskas, T., et al. (2020). Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol 27, 846–854. [CrossRef]
- Jiang, S., Shi, Z., Shu, Y., Song, J., Gao, G. F., Tan, W., et al. (2020). A distinct name is needed for the new coronavirus. The Lancet 395, 949. [CrossRef]
- Karunarathna, S. C., Dong, Y., Karasaki, S., Tibpromma, S., Hyde, K. D., Lumyong, S., et al. Discovery of novel fungal species and pathogens on bat carcasses in a cave in Yunnan Province, China. Emerg Microbes Infect 9, 1554–1566. [CrossRef]
- Masters, P. S. (2006). The molecular biology of coronaviruses. Adv Virus Res 66, 193–292. [CrossRef]
- Matyášek, R., and Kovařík, A. (2020). Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts. Genes (Basel) 11, E761. [CrossRef]
- Millet, J. K., and Whittaker, G. R. (2018). Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology 517, 3–8. [CrossRef]
- Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., et al. (2021). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114–119. [CrossRef]
- Mustafa, Z., Zhanapiya, A., Kalbacher, H., and Burster, T. (2021). Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein. ACS Omega 6, 7181–7185. [CrossRef]
- Naz, A., Shahid, F., Butt, T. T., Awan, F. M., Ali, A., and Malik, A. (2020). Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach. Frontiers in Immunology 11. Available at: https://www.frontiersin.org/article/10.3389/fimmu.2020.01663 [Accessed May 29, 2022].
- Omrani, M., Keshavarz, M., Nejad Ebrahimi, S., Mehrabi, M., McGaw, L. J., Ali Abdalla, M., et al. (2021). Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines. Frontiers in Pharmacology 11, 2115. [CrossRef]
- Plowright, R. K., Parrish, C. R., McCallum, H., Hudson, P. J., Ko, A. I., Graham, A. L., et al. (2017). Pathways to zoonotic spillover. Nat Rev Microbiol 15, 502–510. [CrossRef]
- Randolph, H. E., and Barreiro, L. B. (2020). Herd Immunity: Understanding COVID-19. Immunity 52, 737–741. [CrossRef]
- Roy, S., Ghosh, P., Bandyopadhyay, A., and Basu, S. (2022). Capturing a Crucial ‘Disorder-to-Order Transition’ at the Heart of the Coronavirus Molecular Pathology—Triggered by Highly Persistent, Interchangeable Salt-Bridges. Vaccines 10, 301. [CrossRef]
- Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., et al. (2020). Cell entry mechanisms of SARS-CoV-2. PNAS 117, 11727–11734. [CrossRef]
- Tabibzadeh, A., Esghaei, M., Soltani, S., Yousefi, P., Taherizadeh, M., Tameshkel, F. S., et al. (2021). Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review. Veterinary Medicine and Science 7, 559. [CrossRef]
- The origin of COVID: Did people or nature open Pandora’s box at Wuhan? (2021). Bulletin of the Atomic Scientists. Available at: https://thebulletin.org/2021/05/the-origin-of-covid-did-people-or-nature-open-pandoras-box-at-wuhan/ [Accessed September 30, 2021].
- Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., and Veesler, D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281-292.e6. [CrossRef]
- Wan, Y., Shang, J., Graham, R., Baric, R. S., and Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 94, e00127-20. [CrossRef]
- Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., et al. (2017). Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun 8, 15092. [CrossRef]
- Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).